Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A cAMP binding abnormality in psoriasis.

F Raynaud1, P Gerbaud, O Enjolras

  • 1Laboratoire de Physiopathologie du Développement, CNRS-Ecole Normale Supérieure, Bethesda, Maryland.

Lancet (London, England)
|May 27, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vaccine efficacy against the SARS-CoV-2 Delta variant during a COVID-19 outbreak aboard a military ship.

BMJ military health·2022
Same author

Intercellular ultrafast Ca(2+) wave in vascular smooth muscle cells: numerical and experimental study.

Scientific reports·2016
Same author

Review: hCGs: different sources of production, different glycoforms and functions.

Placenta·2015
Same author

Review: Annexin-A5 and cell membrane repair.

Placenta·2015
Same author

Preface. IFPA meeting 2014.

Placenta·2015
Same author

Drug transporter expression during in vitro differentiation of first-trimester and term human villous trophoblasts.

Placenta·2014

Psoriatic patients show a defect in cAMP-dependent protein kinase (PKA) binding in erythrocyte membranes, correlating with disease severity. Retinoid therapy corrected this biochemical marker, suggesting its utility in managing psoriasis.

Area of Science:

  • Biochemistry
  • Dermatology
  • Molecular Biology

Background:

  • Psoriasis is a chronic inflammatory skin condition with diverse clinical presentations.
  • Understanding the underlying biochemical mechanisms of psoriasis is crucial for effective treatment.
  • Cyclic AMP-dependent protein kinase (PKA) plays a role in cellular signaling pathways.

Purpose of the Study:

  • To investigate the binding ability of the regulatory subunit of PKA to a cAMP analogue in psoriatic patients.
  • To determine if this binding defect correlates with disease severity and clinical evolution.
  • To assess the impact of retinoid therapy on this biochemical marker in psoriasis.

Main Methods:

  • Measured the binding of 8-azido [32P] cAMP to the RI regulatory subunit of PKA in erythrocyte membranes.

Related Experiment Videos

  • Compared binding levels between 34 psoriatic patients and 19 healthy controls.
  • Assessed correlation with Psoriatic Area and Severity Index (PASI) scores and evaluated changes after retinoid treatment.

    • Main Results:

    • Psoriatic patients exhibited significantly lower cAMP analogue binding to PKA compared to normal subjects.
    • A negative correlation was observed between disease severity (PASI score) and PKA binding.
    • Oral retinoid therapy normalized the PKA binding defect in psoriatic patients.

    Conclusions:

    • A biochemical defect in erythrocyte PKA binding is identified in psoriasis, linked to disease severity.
    • This defect is specific to psoriasis and not observed in other dermatitis or inflammatory conditions.
    • The findings suggest PKA binding capacity as a potential biomarker for monitoring psoriasis and guiding retinoid therapy.